Adragos Hub

Plettenberg / Munich / Halden, November 15, 2023 – Prange Group and its affiliate Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for the acquisition of the leading sterile pharmaceutical production site in Halden, Norway. As […]

Dear Valued Partners and Industry Enthusiasts, We are thrilled to announce that the Adragos Pharma team will be participating in one of the pharmaceutical industry’s most prestigious events – CPHI Barcelona 2023, taking place in beautiful Barcelona from October 24th […]

Munich, Germany / Tokyo, Japan, June 15, 2023 — Adragos Pharma GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the divestiture of its subsidiary Toride Pharma K.K., and its associated entity, Toride Asset Trading Co. […]

Adragos on a growth path: Three locations in Europe and five globally Acquisition strengthens Adragos’ end-to-end integrated pharmaceutical product development service offering Agreement on further product development activities for Clinigen Munich / London / Athens, April 3, 2023 – Munich-based […]

Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site […]

Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan Munich / Paris / Tokyo, March 02, 2023 – Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan’s […]